CLINICAL_TRIALS ClinicalTrials.gov record update

A 2-year, Multicenter, Double-masked, Randomized, Parallel Study of the Safety of LUMIGAN® 0.1 mg/mL Compared With LUMIGAN® 0.3 mg/mL in Patients With Glaucoma or Ocular Hypertension

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01298700
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:09.125613+00:00
Published At: 2018-09-17T00:00:00+00:00
Record Updated At: 2018-09-17
Results Posted At: 2018-09-17
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Glaucoma", "Ocular Hypertension"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-09-17"
protocolSection.identificationModule.nctId: "NCT01298700"
protocolSection.identificationModule.officialTitle: "A 2-year, Multicenter, Double-masked, Randomized, Parallel Study of the Safety of LUMIGAN\u00ae 0.1 mg/mL Compared With LUMIGAN\u00ae 0.3 mg/mL in Patients With Glaucoma or Ocular Hypertension"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2018-09-17"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.